Pancreatic Cancer Clinical Trials in New York

Showing 141-145 of 145 trials

A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers

NCT00779688

This registry will collect data from patients routinely undergoing an ERCP and Cellvizio endomicroscopy procedure (and optionally an additional cholangiopancreatoscopy procedure) due to suspected pancreatic or bile duct cancer. The objective is to determine if endomicroscopy images collected using the marketed Cellvizio device may help endoscopists more accurately diagnose, in conjunction with traditional tissue sampling techniques, whether a suspected lesion is malignant or benign.

Pancreatic CancerBile Duct Cancer

Mauna Kea Technologies130 participantsStarted Nov 2008

Aurora, Colorado, United States • Boston, Massachusetts, United States • New York, New York, United States +3 more locations

TERMINATEDPhase 3< 1 mile

Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection

NCT00014651

RATIONALE: Drugs such as vapreotide may prevent complications following pancreatic resection. It is not yet known if vapreotide is more effective than no further therapy in preventing side effects of pancreatic resection. PURPOSE: This randomized phase III trial is studying vapreotide to see how well it works compared to a placebo in preventing complications in patients undergoing surgery for pancreatic cancer.

Pancreatic CancerPerioperative/Postoperative Complications

Mayo ClinicStarted Mar 2001

Birmingham, Alabama, United States • Tampa, Florida, United States • Chicago, Illinois, United States +15 more locations

A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers

Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection

Pancreatic Cancer Trials in Other Cities

Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer

Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer

Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine

Other Conditions in New York